Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
A standing committee for judicial well-being has been formed by the Supreme Court of India…
Donald Trump, United States President selected the Katie Zacharia to become the new White House…
As per reports, the minimum requirement of CRR maintenance in a day by scheduled banks…
On October 9, 2026, an earthquake of magnitude 7.7 hit Panama, causing damage to both…
ICGS Ajit, a domestically designed and constructed Fast Patrol Vessel (FPV), was launched for the…
The Bhagini Nivedita Scheme has been sanctioned by the West Bengal Cabinet, under which single…